Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 63.13
-0.38 (-0.59%)
Jul 24, 2026, 10:57 AM GMT
Arecor Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.99 | -5.09 | -8.9 | -10.42 | -6.95 |
Depreciation & Amortization | 0.22 | 0.36 | 0.5 | 0.34 | 0.17 |
Stock-Based Compensation | 0.32 | 0.16 | 0.64 | 0.5 | 0.48 |
Other Adjustments | -5.04 | -0.08 | -0.25 | -0.28 | 0.5 |
Change in Receivables | -0.37 | 0.38 | -1 | -0.05 | -1.26 |
Changes in Inventories | - | - | 0.36 | 0.59 | - |
Changes in Accounts Payable | 0.32 | -1.07 | 1.38 | -2.2 | 0.84 |
Changes in Other Operating Activities | 1.13 | -3.71 | 1.44 | 0.73 | 0.76 |
Operating Cash Flow | -3.08 | -5.7 | -5.84 | -10.78 | -5.45 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -0.1 | -0.01 | -0.15 | -0.3 | -0.07 |
Sale of Property, Plant & Equipment | 0.01 | - | 0.01 | - | - |
Purchases of Intangible Assets | - | - | - | -0.05 | - |
Proceeds from Sale of Intangible Assets | 5.19 | - | - | - | - |
Purchases of Investments | -3.11 | 1.64 | - | - | - |
Proceeds from Sale of Investments | - | - | 6.38 | -8.04 | - |
Cash Acquisitions | - | - | - | 0.28 | - |
Other Investing Activities | 0.47 | 0.09 | 0.28 | 0.11 | 0 |
Investing Cash Flow | 2.06 | 1.73 | 6.52 | -7.99 | -0.07 |
Short-Term Debt Repaid | - | - | - | -0.3 | - |
Net Short-Term Debt Issued (Repaid) | - | - | - | -0.3 | - |
Long-Term Debt Issued | - | - | - | - | 2.5 |
Long-Term Debt Repaid | - | -0.01 | -0.04 | - | - |
Net Long-Term Debt Issued (Repaid) | - | -0.01 | -0.04 | - | 2.5 |
Issuance of Common Stock | - | 5.78 | - | 5.65 | 18.57 |
Net Common Stock Issued (Repurchased) | - | 5.78 | - | 5.65 | 18.57 |
Other Financing Activities | -0.15 | -0.14 | -0.22 | -0.19 | -0.13 |
Financing Cash Flow | -0.1 | 5.68 | -0.18 | 5.16 | 20.93 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.18 | 0.11 | -0.17 | 0.06 | 0.01 |
Net Cash Flow | -0.05 | -1.97 | 0.5 | -13.61 | 15.41 |
Free Cash Flow | -3.18 | -5.71 | -5.99 | -11.08 | -5.52 |
Free Cash Flow Growth | - | - | - | - | - |
FCF Margin | -185.71% | -347.47% | -131.03% | -461.05% | -476.60% |
Free Cash Flow Per Share | -0.08 | -0.17 | -0.20 | -0.38 | -0.24 |
Levered Free Cash Flow | 2.22 | -14.68 | -5.07 | -10.39 | -1.97 |
Unlevered Free Cash Flow | 2.43 | -9.68 | -5.29 | -10.17 | -4.02 |